These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-005168-94 Multicenter Phase II- trial to investigate safety and efficacy of an Adjuvant Therapy with Gemcitabine and Erbitux® in patients with R0 or R1 resected Pancreatic cancer bad-data
Not reported Terminated 2006-004374-27 Prospective, randomized, doubleblind, placebo-controlled trial on changes in acetylcholine receptor antibody titres in autoimmune myasthenia gravis after influenza vaccination (ProPATIent) 2010-02-17 due-trials
Completed, but no date Terminated 2006-005819-10 Influence of tiotropium bromide (Spiriva ®) plus salbutamol versus salbutamol on the mucin secretion and sputum properties in subjects with a COPD exacerbation -TIBROMUC- bad-data
Not reported Terminated 2007-006051-39 Pharmakokinetic investigation on the tissue penetration of moxifloxacin within the pericardial space 2012-03-28 due-trials
Ongoing 2008-001755-22 Stealth liposomal doxorubicin vs carboplatin/paclitaxel in patients with ovarian cancer recurrence between six and twelve months after previous platinum based chemotherapy: phase III multicenter rando... not-yet-due
Not reported 2008-003392-40 Untersuchung des Einflusses von Carbamazepin auf die mittels transkranieller Magnetstimulation gemessene kortikale Exzitabilität des menschlichen Motorkortex in Abhängigkeit vom Polymorphismus für SCN... 2011-06-24 due-trials
Ongoing 2009-011088-35 Pituitary adenylate cyclase activating polypeptide in stressed patients with Multiple sclerosis (MS) or clinically isolated syndrome suggestive for MS under treatment with glatiramer acetate (PACAMUS)... not-yet-due
Completed, report not yet due Terminated 2010-018539-16 A double-blind, placebo-controlled, randomized, multi-center phase II trial to assess the efficacy of Sorafenib-maintenance therapy in Flt3-ITD positive AML in complete hematological remission after a... 2018-10-31 not-yet-due
Not reported 2010-020299-42 A randomized, placebo-controlled, double-blind, multi-center trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA (NIC-PD) 2017-02-15 due-trials
Not reported Terminated 2011-004361-32 Effect of simvastatin in combination with a superpotent topical corticosteroid in bullous pemphigoid 2016-02-02 due-trials
Completed, but no date Terminated 2012-003750-89 A placebo-controlled, double blind, randomised trial with crossover-design investigating the effect of oxytocin nasal spray on neuronal processes of empathy bad-data
Not reported 2012-004585-18 Perioperative administration of Tapentadol – tolerance, safety and effects on postoperative rehabilitation and quality of life. Randomized, controlled study to compare the analgesic therapy with tape... 2016-09-30 due-trials
Ongoing 2017-003688-37 Phosphodiesterase-5 inhibition in patients with heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension (PASSION), A randomized, placebo-controlled,... not-yet-due